Celldex Presents Data Demonstrating Profound Long Term Improvement in Angioedemain Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI 2025
June 14, 2025 10:48 ET | Source: Celldex Therapeutics, Inc. 77% of…
Eternal’s Initiatives to Support Delivery Partners during the Heatwave
NEW DELHI, June 12, 2025 /PRNewswire/ -- In light of the ongoing…
FIS Alpine Meeting: Focus on Athlete Safety and Season Outlook
May 12, 2025 - During the FIS Spring Meetings in Vilamoura (POR),…
New global Digital Economy Trust Index exposes correlation between GDP growth and consumer trust in online payments
Checkout.com launches inaugural Digital Economy Trust Index, which ranks countries based on…
Tata Tea JaagoRe’s AI campaign champions the power of collective actions for a positive climate impact
The initiative measures the positive impact of daily 'green' actions by individuals…
Silicon Motion Announces Results for the Period Ended March 31, 2025
Business Highlights First quarter of 2025 sales decreased 13% Q/Q and decreased…
COSCIENS Biopharma Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Corporate Update
Fully repositioned as a pure-play natural-based product company following strategic review and…
Annexon Highlights Leadership in Advancing Clinical Research and Education for Guillain-Barr Syndrome (GBS) at American Academy of Neurology (AAN) 2025 Annual Meeting
April 03, 2025 18:18 ET | Source: Annexon Biosciences Oral Plenary Presentation…
MEXC Partners with Hacken to Strengthen Platform Security
VICTORIA, Seychelles, March 5, 2025 /PRNewswire/ -- MEXC, the world's leading cryptocurrency…
BioCardia Announces Primary Outcome Measures Data Freeze in CardiAMP Heart Failure Trial for Presentation at the American College of Cardiology 2025 Scientific Sessions
SUNNYVALE, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. , a global…